课题基金 / 基金详情

Single-cycle Infectious Candid#1 to Study Hemorrhagic Fever New World Arenavirus

Single-cycle Infectious Candid#1 to Study Hemorrhagic Fever New World Arenavirus
单周期传染性坦诚
批准号:
8385029
负责人:
Luis Martinez-Sobrido
金额:
$7.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2014-06-30

项目摘要

项目成果

Luis Martinez-Sobrido的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):ARENAV包括几种人类出血热(HF)疾病的病原体,这些疾病与高发病率和显著死亡率有关。此外,武器化形式的阿拉伯病毒作为生物恐怖主义的媒介构成严重威胁。由于缺乏获得许可的疫苗,以及目前仅限于标签外使用利巴韦林的抗病毒疗法,这种疗法只有部分有效,而且往往伴随着严重的副作用,加剧了对阿雷诺病毒造成的公共卫生关切。HF竞技场病毒研究的局限性包括在生物安全级别(BSL)4级实验室下操纵这些制剂的活体形式,以及要求对病毒进行二次检测。开发有效的单周期感染替代物,允许在不那么严格的BSL2设备下研究HF arena病毒,并表达便于病毒检测的报告基因,将有助于使用与高通量筛选(HTS)技术兼容的安全、敏感和特异的筛查方法来识别预防和治疗策略。此外,它们还将代表有希望的疫苗方法,以规避对可能导致疾病的减毒疫苗株可能失控复制的担忧。最近,我们首次描述了一种单周期感染性、表达报告基因的旧世界淋巴细胞性脉络膜脑膜炎病毒(LCMV)的产生,其中我们用报告绿色荧光蛋白(GFP)rLCMV?GP/GFP取代了病毒糖蛋白(GP)。通过与表达LCMV gP的细胞系进行基因反式互补,获得了感染性病毒。该系统使我们能够研究病毒的多个方面,并开发筛选分析方法,用于中和抗体的检测和定量以及病毒抑制剂的鉴定。我们还通过建立表达LASV gp的细胞系和LASV gp伪型rLCMV?gp/GFP,将我们的工作扩展到拉萨病毒(Lasa Virus,LASV),LASV是旧大陆阿拉伯病毒的一个HF成员。由于旧世界和新世界竞技场病毒的储存库、用于病毒进入的细胞受体和RNA基因组组成不同,开发有效的替代物来研究新世界竞技场病毒势在必行,以便为研究人员提供一种研究病毒生物学的方方面面的方法,以识别抗病毒药物,以及 在不那么严格的生物安全实验室下开发针对新世界禽流感病毒的疫苗。在这项应用中,我们建议通过产生一种单周期感染、表达报告的减毒疫苗株CARTID#1(rcan?GP/GFP),将我们最近描述的技术扩展到新世界禽流感病毒的研究中。 公共卫生相关性:ARENAV是重要的病毒病原体,可在人类中引起常见的、在某些情况下是严重的感染。其中,出血热病毒是一个严重的公共卫生问题,也是生物恐怖主义的威胁因素。目前还没有获得许可的抗ArenaVirus疫苗,目前的抗ArenaVirus治疗仅限于使用利巴韦林,利巴韦林只有部分疗效,而且往往与严重副作用有关。我们的目标是通过产生一种单周期传染性的、记者表达的、减毒的疫苗株CARTID#1,来产生一种有效的替代系统,以促进在不那么严格的生物安全条件下对家庭中的HF新世界成员进行研究。
英文摘要
DESCRIPTION (provided by applicant): Arenaviruses include several causative agents of Hemorrhagic Fever (HF) disease in humans that are associated with high morbidity and significant mortality. Moreover, weaponized forms of arenaviruses pose a serious threat as agents of bioterrorism. Public health concerns posed by arenaviruses are aggravated by the lack of licensed vaccines and by current anti-arenavirus therapy limited to the off-label use of ribavirin, which is only partially effective and often associated with severe side effects. Limitations in the study of HF arena-viruses include the manipulation of live forms of these agents under BioSafety Level (BSL) 4 laboratories and the requirement of secondary assays for detection of the virus. Development of valid single-cycle infectious surrogates that allow the study of HF arenavirus under less-strict BSL2 facilities and that express a reporter gene for easy viral detection will facilitate the identification of prophylactic and therapeutic strategies using safe, sensitive and specific screening assays compatible with High Throughput Screening (HTS) technologies. Furthermore, they will also represent promising vaccine approaches that circumvent concerns about potential out-of-control replication of attenuated vaccine strains that might lead to disease. Recently, we have described, for the first time, the generation of a single-cycle infectious, reporter-expressing, Old World Lymphocytic Choriomeningitis Virus (LCMV) where we replaced the viral glycoprotein (GP) with a reporter green fluorescent protein (GFP), rLCMV?GP/GFP. Infectious virus was achieved via genetic trans- complementation with cell lines constitutively expressing LCMV GP. This system allowed us to study multiple aspects of the virus and to develop screening assays for detection and quantification of neutralizing antibodies and identification of viral inhibitors. We were also able to extend our work to Lassa virus (LASV), an HF member of the Old World arenavirus, by generating LASV GP-expressing cell lines and LASV GP-pseudotyped rLCMV?GP/GFP. Since Old World and New World arena-viruses differ in their reservoirs, cellular receptor use for viral entry, and RNA genome composition, the development of valid surrogates to study New World arenavirus is imperative to provide researchers a way to study all aspects of the virus biology, to identify antivirals, and to develop vaccines against New World arenaviruses under less strict biosafety laboratories. In this application we propose to expand our recently described technology to the study of New World arenavirus by generating a single-cycle infectious, reporter-expressing, attenuated vaccine strain Candid#1 (rCan?GP/GFP). PUBLIC HEALTH RELEVANCE: Arenaviruses are important viral pathogens that cause common and in some case severe infections in humans. Among them, Hemorrhagic Fever (HF) arenaviruses represent a serious public health problem as well as a threat as agents of bioterrorism. No licensed anti-arenavirus vaccines are available, and current anti-arenavirus therapy is limited to the use of ribavirin, which is only partially effective and often associated with severe side effects. Our goal is to generate a valid surrogate system that facilitates the study of HF New World members in the family under less-strict biosafety conditions by generating a single-cycle infectious, reporter-expressing, attenuated vaccine strain Candid#1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Attenuation of Lassa Virus Via Codon Deoptimization
Roles of the Nucleoprotein 3'-5' Exonuclease Domain in Arenavirus Biology
  • 批准号:
    9901456
  • 项目类别:
  • 资助金额:
    $43.44万
  • 财政年份:
    2019
  • 负责人:
    Luis Martinez-Sobrido
  • 依托单位:
Roles of the Nucleoprotein 3'-5' Exonuclease Domain in Arenavirus Biology
  • 批准号:
    10395433
  • 项目类别:
  • 资助金额:
    $43.44万
  • 财政年份:
    2019
  • 负责人:
    Luis Martinez-Sobrido
  • 依托单位:
Roles of the Nucleoprotein 3'-5' Exonuclease Domain in Arenavirus Biology
  • 批准号:
    9765080
  • 项目类别:
  • 资助金额:
    $45.78万
  • 财政年份:
    2019
  • 负责人:
    Luis Martinez-Sobrido
  • 依托单位:
海外基金